Companies: 10,795·Total market cap: $144.5T
BrightSpring Health Services, Inc. Common Stock

BrightSpring Health Services, Inc. Common Stock

BTSGNASDAQHealthcare● Active
$57.40
+$0.00(+0.00%)
Market Cap$11.1B
P/E Ratio
52W High$62.11
52W Low$19.01
Overview

BrightSpring Health Services, Inc. Common Stock (BTSG) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

btsg · stock forecast · 12 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 12 Wall Street analysts in the past 3 months

SellBuy

Buy

12 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
12
Hold
0
Sell
0
Strong Sell
0
Total: 12 · Buy rate: 100.0%

12-Month Price Target

High

$71.00

Consensus

$60.45

+5.3% upside

Low

$45.00

Median: $61 · Last Close: $57.40

The BrightSpring Health Services, Inc. Common Stock (BTSG) analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month BTSG price target is $60.45, representing +5.3% upside from the current price of $57.40.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $60 (5.3%)

Consensus Target

$60.45

5.3% upside

High Target

$71

23.7%

Low Target

$45

-21.6%

Current Price

$57.40

as of today

Based on analyst price targets, the BTSG stock price prediction for the next 12 months ranges from $45 to $71. The consensus BTSG price forecast of $60.45 implies 5.3% upside from the current price of $57.40.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$58.111.24%

1-day model range: $57.81–$58.41. Peak: $58.41 (+1.24%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$92+60.0%
2028$128+122.4%
2029$160+178.8%
2030$186+224.7%
2031+259.5%
Confidence:MediumCapped at 60% annual limit

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%7%43%
7Buy
1Neutral
6Sell
RSI (14)48.4Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · BTSG · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$59.00SELL
MA 10$59.69SELL
MA 20$58.23SELL
MA 50$51.34BUY
MA 100$45.82BUY
MA 200$38.77BUY
Current $BTSG · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$58.68SELL
EMA 10$58.84SELL
EMA 20$57.48SELL
EMA 50$52.68BUY
EMA 100$47.37BUY
EMA 200$40.49BUY
Current $BTSG · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Morgan Stanley2026-06-02
Maintains
OverweightOverweight
Morgan Stanley2026-05-06
Maintains
OverweightOverweight
Mizuho2026-05-05
Maintains
OutperformOutperform
Stephens & Co.2026-05-04
Maintains
OverweightOverweight
BTIG2026-05-04
Maintains
BuyBuy
Keybanc2026-05-04
Maintains
OverweightOverweight
Wells Fargo2026-05-04
Maintains
OverweightOverweight
BMO Capital2026-05-04
Maintains
OutperformOutperform
TD Cowen2026-05-04
Maintains
BuyBuy
BTIG2026-03-19
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on BrightSpring Health Services, Inc. Common Stock (BTSG) stock. Of the recent 44 rating actions, 1 were upgrades and 0 were downgrades. 12 analysts currently cover BTSG.

Analyst Recommendation Trends

Buy ratings413
Hold ratings00
Sell ratings00

BTSG analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$15.1B

↓ 23.4% YoY

Revenue Next Year

$17.1B

↑ 13.6% YoY

EPS This Year

$1.68

EPS Next Year

$2.11

↑ 25.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BTSG EPS of $1.68 for the current fiscal year, based on estimates from 8 analysts. The BTSG revenue forecast is $15.1B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BTSG stock forecast is supported by two independent data sources: analyst consensus ratings from 12 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BTSG price target is $60.45 (+5.3% upside), with an analyst consensus of Buy.

The BTSG short-term stock prediction for tomorrow is $58.11 (+1.24%). The BTSG stock price prediction for 2027 estimates an average of $92. The BTSG stock prediction for 2030 projects a range of $176–$197.

BrightSpring Health Services, Inc. Common Stock trades on NASDAQ under the ticker BTSG. The BTSG stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BTSG forecast · 8 questions

According to 12 Wall Street analysts, the average 12-month BTSG price target is $60.45, with a high forecast of $71.00 and a low of $45.00. The median price target is shown in the chart above when available. This implies +5.3% potential upside from the current price of $57.40.

BTSG price targetWhat is BTSG price targetBTSG analyst price targetBTSG 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.